The global market for Diagnostic Imaging is projected to reach US$31.8 billion by 2025

New York, Oct. 22, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Diagnostic Imaging Industry” – https://www.reportlinker.com/p05798349/?utm_source=GNW
Advanced imaging capabilities provide huge benefits such as early detection; better diagnosis; detailed visualization of anatomical structures; easy and faster physician understanding of disease complications; better clinical decisions; reduced risk of errors; safer in terms of medical radiation exposure; and better patient outcome. Demand for diagnostic imaging services is poised to benefit from the growing global burden of disease which is directly linked to increasing life expectancy. With the average human living longer due to improvements in acute care, the risk of developing chronic diseases remains high leading to higher number of years lived with disability. Medications that slow progress of disease and prevent death such as BP, cholesterol drugs for cardiovascular diseases and new generation drugs for diabetics are responsible for the rise in life expectancy. For instance, drugs like Metformin has significantly increased survival rate in patients with diabetes and comorbid heart diseases. However, prolonged life with chronic diabetes leads to other diabetes-related health problems such as damage to eyes, kidneys, feet, nerves, large blood vessels of the heart, brain and legs. Higher number of years lived in less-than-ideal health pushes up demand for healthcare services. With medical imaging being the starting point for timely care and treatment, diagnostic imaging is the chief beneficiary of the aging population living with chronic diseases.

Popular diagnostic imaging technologies currently in use include X-rays, CT scan (computed tomography scan), MRI (magnetic resonance imaging), ultrasound, nuclear medicine imaging, including positron-emission tomography (PET), and optical imaging. The field of diagnostic imaging is effervescent and continuously evolving and changing with significant funds for R&D being continuously injected to develop more advanced imaging technologies that provide accurate and precise diagnosis. Few of the ongoing innovations include hybrid imaging technology that combines PET/CT, PET/MRI and/or SPECT/CT systems; development of imaging systems with lower doses of ionizing radiation or non-ionizing radiation such as Optical Coherence Tomography (OCT), Photoacoustic Imaging, Diffuse Optical Tomography (DOT), Raman Spectroscopy & Photoactivated Localization Microscopy (PALM), Florescence Imaging, Near-infrared fluorescence imaging, Bioluminescent Imaging (BLI); use of contrast Agents in diagnostic imaging; development of cryogen-free MRI imaging systems and automated CT scanners, among others. Nuclear imaging market is especially poised to grow supported by the epidemic spread of cancer. Nuclear medicine is an evolving area of radiology that utilizes tiny amounts of radioactive dye (tracer) to highlight damaged or infected tissues and cancer cells. Types of nuclear imaging modalities that utilize radioisotopes include bone density scan, Cardiac PET perfusion, Cardiac PET sarcoid, Cardiac SPECT perfusion, Cardiac PET viability, PET/CT scanning, MIBG (metaiodobenzylguanidine) scans, gallium scan, and SPECT. Nuclear imaging equipment, over the decades, has witnessed several advances at the technological front. Technological advances continue to drive the market, with some of these focusing in improving systems in order to enhance clinical decision-making for clinicians as well as patients. Rising density of diagnostic imaging units is resulting in growing number of imaging procedures performed each day. CT & MRI scans dominate the diagnostic radiology industry, with the United States leading the world in terms of volume of procedures performed. The United States and Europe represent large markets worldwide with a combined share of 59% of the market. China ranks as the fastest growing market with a CAGR of 7.6% over the analysis period supported by the country’s rapidly developing healthcare system under the “Healthy China 2020” initiative which is largely focused on chronic disease prevention.

Read the full report: https://www.reportlinker.com/p05798349/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Diagnostic Imaging – A Prelude
Global Diagnostic Imaging Market Set for a Strong Growth
Developed Regions: The Dominant Markets for Diagnostic Imaging
Developing Regions Exhibit the Fastest Growth
Increase in Number of Hospitals & Clinics Infuses Momentum in
Developing Regions
Key Players
Global Competitor Market Shares
Diagnostic Imaging Competitor Market Share Scenario Worldwide
(in %): 2019
Segment Analysis
MRI Dominates the Global Diagnostic Imaging Market
Equipment Density Correlates With Number of Imaging Procedures:
Magnetic Resonance Imaging (MRI) Units in Select Countries:
(Per Million Population) for the Year 2019
Global MRI Market by Application (2019): Percentage Breakdown
of Procedure Volume for Brain, Cardiac & Vascular,
Extremities, Full Body, Mammography, Spine and Others
Computed Tomography System (CT Scanner)
Ultrasound
Global Ultrasound Systems Market by Portability Type (2019):
Percentage Breakdown of Unit Sales for Cart Systems and Point-of
Care Systems
X-Ray
Nuclear Medicine
SPECT Dominates the Nuclear Medicine Market
Worldwide Installed Base of Nuclear Imaging Equipment by
Modality (2019): Percentage Breakdown of Units Installed for
PET and SPECT
PET
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS
Agfa-Gevaert N.V. (Belgium
Canon Medical Systems Corporation (Japan)
Carestream Health, Inc. (USA)
Esaote S.p.A. (Italy)
Fujifilm Corporation (Japan)
GE Healthcare (UK)
Koninklijke Philips N.V. (Netherlands)
Konica Minolta Inc. (Japan)
Hitachi Ltd. (Japan)
Hologic, Inc. (USA)
HOYA Group Pentax (Japan)
Samsung Medison Co., Ltd. (Korea)
Shimadzu Corporation (Japan)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China
Siemens Healthineers (Germany)

3. MARKET TRENDS & DRIVERS
Rapidly Growing Geriatric Population and the Rise in Associated
Diseases Catalyze Growth
Rapidly Aging Population Spurs Demand for Diagnostic Imaging:
Global Population of 65+ Individuals (In 000s) by Region for
the Years 2015, 2020, 2025, 2030 & 2050
Rising Incidence of Chronic Diseases Propels the Demand for
Medical Imaging
Rising Prevalence of Chronic Diseases Amplifies the Volume of
Diagnostic Imaging Procedures: Global Cost of Chronic Diseases
(In US$ Billion) for the Years 2018 and 2030
Growing Emphasis on Early Diagnosis is a Driving Factor for
Diagnostic Imaging
Rising Healthcare Expenditure Impels Global Market
Oncology Diagnostic Imaging to Witness Rapid Growth
Global Cancer Incidence by Type: 2018
Technological Innovations Drive the Global Diagnostic Imaging
Market
Growing Adoption of Hybrid Diagnostic Imaging Modalities
PET-CT: The Most Successful Fusion Imaging Technique
SPECT-CT
PET/MRI Continues to Makes Inroads
Ultrasound and MRI Imaging: An Efficient Combination
Rapid Adoption of Contrast-Enhanced Ultrasound (CEUS) Drives
Market Growth
CT Imaging Gains Popularity
CCTA Gaining Traction in Coronary Arteries Imaging
Use of Blockchain in Diagnostic Imaging

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Diagnostic Imaging
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 2: World Historic Review for Diagnostic Imaging by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 3: World 15-Year Perspective for Diagnostic Imaging by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for X-ray Imaging by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 5: World Historic Review for X-ray Imaging by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019

Table 6: World 15-Year Perspective for X-ray Imaging by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for MRI by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027

Table 8: World Historic Review for MRI by Geographic Region –
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets – Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019

Table 9: World 15-Year Perspective for MRI by Geographic Region –
Percentage Breakdown of Value Sales for USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Ultrasound by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 11: World Historic Review for Ultrasound by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019

Table 12: World 15-Year Perspective for Ultrasound by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for CT by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027

Table 14: World Historic Review for CT by Geographic Region –
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets – Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019

Table 15: World 15-Year Perspective for CT by Geographic Region –
Percentage Breakdown of Value Sales for USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Nuclear Imaging
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 17: World Historic Review for Nuclear Imaging by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 18: World 15-Year Perspective for Nuclear Imaging by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Hospitals by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 20: World Historic Review for Hospitals by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019

Table 21: World 15-Year Perspective for Hospitals by Geographic
Region – Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Diagnostic
Imaging Centers by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027

Table 23: World Historic Review for Diagnostic Imaging Centers
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 24: World 15-Year Perspective for Diagnostic Imaging
Centers by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 25: World Current & Future Analysis for Other End-Uses by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 26: World Historic Review for Other End-Uses by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 27: World 15-Year Perspective for Other End-Uses by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Diagnostic Imaging Market Share (in %) by Company: 2019 & 2025
Market Analytics
Table 28: USA Current & Future Analysis for Diagnostic Imaging
by Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging – Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027

Table 29: USA Historic Review for Diagnostic Imaging by Product –
X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging
Markets – Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019

Table 30: USA 15-Year Perspective for Diagnostic Imaging by
Product – Percentage Breakdown of Value Sales for X-ray
Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years
2012, 2020 & 2027

Table 31: USA Current & Future Analysis for Diagnostic Imaging
by End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses – Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027

Table 32: USA Historic Review for Diagnostic Imaging by End-Use –
Hospitals, Diagnostic Imaging Centers and Other End-Uses
Markets – Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019

Table 33: USA 15-Year Perspective for Diagnostic Imaging by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2020 & 2027

CANADA
Table 34: Canada Current & Future Analysis for Diagnostic
Imaging by Product – X-ray Imaging, MRI, Ultrasound, CT and
Nuclear Imaging – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 35: Canada Historic Review for Diagnostic Imaging by
Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 36: Canada 15-Year Perspective for Diagnostic Imaging by
Product – Percentage Breakdown of Value Sales for X-ray
Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years
2012, 2020 & 2027

Table 37: Canada Current & Future Analysis for Diagnostic
Imaging by End-Use – Hospitals, Diagnostic Imaging Centers and
Other End-Uses – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 38: Canada Historic Review for Diagnostic Imaging by
End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 39: Canada 15-Year Perspective for Diagnostic Imaging by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2020 & 2027

JAPAN
Table 40: Japan Current & Future Analysis for Diagnostic
Imaging by Product – X-ray Imaging, MRI, Ultrasound, CT and
Nuclear Imaging – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 41: Japan Historic Review for Diagnostic Imaging by
Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 42: Japan 15-Year Perspective for Diagnostic Imaging by
Product – Percentage Breakdown of Value Sales for X-ray
Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years
2012, 2020 & 2027

Table 43: Japan Current & Future Analysis for Diagnostic
Imaging by End-Use – Hospitals, Diagnostic Imaging Centers and
Other End-Uses – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 44: Japan Historic Review for Diagnostic Imaging by
End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 45: Japan 15-Year Perspective for Diagnostic Imaging by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2020 & 2027

CHINA
Table 46: China Current & Future Analysis for Diagnostic
Imaging by Product – X-ray Imaging, MRI, Ultrasound, CT and
Nuclear Imaging – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 47: China Historic Review for Diagnostic Imaging by
Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 48: China 15-Year Perspective for Diagnostic Imaging by
Product – Percentage Breakdown of Value Sales for X-ray
Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years
2012, 2020 & 2027

Table 49: China Current & Future Analysis for Diagnostic
Imaging by End-Use – Hospitals, Diagnostic Imaging Centers and
Other End-Uses – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 50: China Historic Review for Diagnostic Imaging by
End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 51: China 15-Year Perspective for Diagnostic Imaging by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2020 & 2027

EUROPE
Market Facts & Figures
European Diagnostic Imaging Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Market Analytics
Table 52: Europe Current & Future Analysis for Diagnostic
Imaging by Geographic Region – France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets – Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027

Table 53: Europe Historic Review for Diagnostic Imaging by
Geographic Region – France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets – Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019

Table 54: Europe 15-Year Perspective for Diagnostic Imaging by
Geographic Region – Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 55: Europe Current & Future Analysis for Diagnostic
Imaging by Product – X-ray Imaging, MRI, Ultrasound, CT and
Nuclear Imaging – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 56: Europe Historic Review for Diagnostic Imaging by
Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 57: Europe 15-Year Perspective for Diagnostic Imaging by
Product – Percentage Breakdown of Value Sales for X-ray
Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years
2012, 2020 & 2027

Table 58: Europe Current & Future Analysis for Diagnostic
Imaging by End-Use – Hospitals, Diagnostic Imaging Centers and
Other End-Uses – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 59: Europe Historic Review for Diagnostic Imaging by
End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 60: Europe 15-Year Perspective for Diagnostic Imaging by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2020 & 2027

FRANCE
Table 61: France Current & Future Analysis for Diagnostic
Imaging by Product – X-ray Imaging, MRI, Ultrasound, CT and
Nuclear Imaging – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 62: France Historic Review for Diagnostic Imaging by
Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 63: France 15-Year Perspective for Diagnostic Imaging by
Product – Percentage Breakdown of Value Sales for X-ray
Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years
2012, 2020 & 2027

Table 64: France Current & Future Analysis for Diagnostic
Imaging by End-Use – Hospitals, Diagnostic Imaging Centers and
Other End-Uses – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 65: France Historic Review for Diagnostic Imaging by
End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 66: France 15-Year Perspective for Diagnostic Imaging by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2020 & 2027

GERMANY
Table 67: Germany Current & Future Analysis for Diagnostic
Imaging by Product – X-ray Imaging, MRI, Ultrasound, CT and
Nuclear Imaging – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 68: Germany Historic Review for Diagnostic Imaging by
Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 69: Germany 15-Year Perspective for Diagnostic Imaging by
Product – Percentage Breakdown of Value Sales for X-ray
Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years
2012, 2020 & 2027

Table 70: Germany Current & Future Analysis for Diagnostic
Imaging by End-Use – Hospitals, Diagnostic Imaging Centers and
Other End-Uses – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 71: Germany Historic Review for Diagnostic Imaging by
End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 72: Germany 15-Year Perspective for Diagnostic Imaging by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2020 & 2027

ITALY
Table 73: Italy Current & Future Analysis for Diagnostic
Imaging by Product – X-ray Imaging, MRI, Ultrasound, CT and
Nuclear Imaging – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 74: Italy Historic Review for Diagnostic Imaging by
Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 75: Italy 15-Year Perspective for Diagnostic Imaging by
Product – Percentage Breakdown of Value Sales for X-ray
Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years
2012, 2020 & 2027

Table 76: Italy Current & Future Analysis for Diagnostic
Imaging by End-Use – Hospitals, Diagnostic Imaging Centers and
Other End-Uses – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 77: Italy Historic Review for Diagnostic Imaging by
End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 78: Italy 15-Year Perspective for Diagnostic Imaging by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2020 & 2027

UNITED KINGDOM
Table 79: UK Current & Future Analysis for Diagnostic Imaging
by Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging – Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027

Table 80: UK Historic Review for Diagnostic Imaging by Product –
X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging
Markets – Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019

Table 81: UK 15-Year Perspective for Diagnostic Imaging by
Product – Percentage Breakdown of Value Sales for X-ray
Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years
2012, 2020 & 2027

Table 82: UK Current & Future Analysis for Diagnostic Imaging
by End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses – Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027

Table 83: UK Historic Review for Diagnostic Imaging by End-Use –
Hospitals, Diagnostic Imaging Centers and Other End-Uses
Markets – Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019

Table 84: UK 15-Year Perspective for Diagnostic Imaging by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2020 & 2027

SPAIN
Table 85: Spain Current & Future Analysis for Diagnostic
Imaging by Product – X-ray Imaging, MRI, Ultrasound, CT and
Nuclear Imaging – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 86: Spain Historic Review for Diagnostic Imaging by
Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 87: Spain 15-Year Perspective for Diagnostic Imaging by
Product – Percentage Breakdown of Value Sales for X-ray
Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years
2012, 2020 & 2027

Table 88: Spain Current & Future Analysis for Diagnostic
Imaging by End-Use – Hospitals, Diagnostic Imaging Centers and
Other End-Uses – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 89: Spain Historic Review for Diagnostic Imaging by
End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 90: Spain 15-Year Perspective for Diagnostic Imaging by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2020 & 2027

RUSSIA
Table 91: Russia Current & Future Analysis for Diagnostic
Imaging by Product – X-ray Imaging, MRI, Ultrasound, CT and
Nuclear Imaging – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 92: Russia Historic Review for Diagnostic Imaging by
Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 93: Russia 15-Year Perspective for Diagnostic Imaging by
Product – Percentage Breakdown of Value Sales for X-ray
Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years
2012, 2020 & 2027

Table 94: Russia Current & Future Analysis for Diagnostic
Imaging by End-Use – Hospitals, Diagnostic Imaging Centers and
Other End-Uses – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 95: Russia Historic Review for Diagnostic Imaging by
End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 96: Russia 15-Year Perspective for Diagnostic Imaging by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2020 & 2027

REST OF EUROPE
Table 97: Rest of Europe Current & Future Analysis for
Diagnostic Imaging by Product – X-ray Imaging, MRI, Ultrasound,
CT and Nuclear Imaging – Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027

Table 98: Rest of Europe Historic Review for Diagnostic Imaging
by Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 99: Rest of Europe 15-Year Perspective for Diagnostic
Imaging by Product – Percentage Breakdown of Value Sales for
X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the
Years 2012, 2020 & 2027

Table 100: Rest of Europe Current & Future Analysis for
Diagnostic Imaging by End-Use – Hospitals, Diagnostic Imaging
Centers and Other End-Uses – Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 101: Rest of Europe Historic Review for Diagnostic
Imaging by End-Use – Hospitals, Diagnostic Imaging Centers and
Other End-Uses Markets – Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 102: Rest of Europe 15-Year Perspective for Diagnostic
Imaging by End-Use – Percentage Breakdown of Value Sales for
Hospitals, Diagnostic Imaging Centers and Other End-Uses for
the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 103: Asia-Pacific Current & Future Analysis for
Diagnostic Imaging by Geographic Region – Australia, India,
South Korea and Rest of Asia-Pacific Markets – Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027

Table 104: Asia-Pacific Historic Review for Diagnostic Imaging
by Geographic Region – Australia, India, South Korea and Rest
of Asia-Pacific Markets – Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 105: Asia-Pacific 15-Year Perspective for Diagnostic
Imaging by Geographic Region – Percentage Breakdown of Value
Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2020 & 2027

Table 106: Asia-Pacific Current & Future Analysis for
Diagnostic Imaging by Product – X-ray Imaging, MRI, Ultrasound,
CT and Nuclear Imaging – Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027

Table 107: Asia-Pacific Historic Review for Diagnostic Imaging
by Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 108: Asia-Pacific 15-Year Perspective for Diagnostic
Imaging by Product – Percentage Breakdown of Value Sales for
X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the
Years 2012, 2020 & 2027

Table 109: Asia-Pacific Current & Future Analysis for
Diagnostic Imaging by End-Use – Hospitals, Diagnostic Imaging
Centers and Other End-Uses – Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 110: Asia-Pacific Historic Review for Diagnostic Imaging
by End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 111: Asia-Pacific 15-Year Perspective for Diagnostic
Imaging by End-Use – Percentage Breakdown of Value Sales for
Hospitals, Diagnostic Imaging Centers and Other End-Uses for
the Years 2012, 2020 & 2027

AUSTRALIA
Table 112: Australia Current & Future Analysis for Diagnostic
Imaging by Product – X-ray Imaging, MRI, Ultrasound, CT and
Nuclear Imaging – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 113: Australia Historic Review for Diagnostic Imaging by
Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 114: Australia 15-Year Perspective for Diagnostic Imaging
by Product – Percentage Breakdown of Value Sales for X-ray
Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years
2012, 2020 & 2027

Table 115: Australia Current & Future Analysis for Diagnostic
Imaging by End-Use – Hospitals, Diagnostic Imaging Centers and
Other End-Uses – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 116: Australia Historic Review for Diagnostic Imaging by
End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 117: Australia 15-Year Perspective for Diagnostic Imaging
by End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2020 & 2027

INDIA
Table 118: India Current & Future Analysis for Diagnostic
Imaging by Product – X-ray Imaging, MRI, Ultrasound, CT and
Nuclear Imaging – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 119: India Historic Review for Diagnostic Imaging by
Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 120: India 15-Year Perspective for Diagnostic Imaging by
Product – Percentage Breakdown of Value Sales for X-ray
Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years
2012, 2020 & 2027

Table 121: India Current & Future Analysis for Diagnostic
Imaging by End-Use – Hospitals, Diagnostic Imaging Centers and
Other End-Uses – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 122: India Historic Review for Diagnostic Imaging by
End-Use – Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 123: India 15-Year Perspective for Diagnostic Imaging by
End-Use – Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2020 & 2027

SOUTH KOREA
Table 124: South Korea Current & Future Analysis for Diagnostic
Imaging by Product – X-ray Imaging, MRI, Ultrasound, CT and
Nuclear Imaging – Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 125: South Korea Historic Review for Diagnostic Imaging
by Product – X-ray Imaging, MRI, Ultrasound, CT and Nuclear
Imaging Markets – Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 126: South Korea 15-Year Perspective for Diagnostic
Imaging by Product – Percentage Breakdown of Value Sales for
X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the
Years 2012, 2020 & 2027

Table 127: South Korea Current & Future Analysis for Diagnostic
Imaging by End-Use – Hospitals, Diagnostic Imaging Centers and

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05798349/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________

Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001